×
About 31,143 results

ALLMedicine™ Glaucoma Center

Research & Reviews  10,691 results

Use of antihypertensive medications and the risk of glaucoma onset: Findings from the 4...
https://doi.org/10.1111/ceo.14107
Clinical & Experimental Ophthalmology; Yuan Y, Wang W et. al.

May 20th, 2022 - Abnormal blood pressure is a potential risk factor for glaucoma. However, the role of antihypertensive medications on glaucoma pathogenesis is controversial. This study aims to investigate the association between use of antihypertensive medication...

Clinical and Molecular Studies in Families With Inherited Eye Disease
https://clinicaltrials.gov/ct2/show/NCT02771236

May 20th, 2022 - Objective: This project, Clinical and Molecular Studies in Families with Inherited Eye Disease will study inherited eye diseases, both Mendelian and complex age related inherited eye diseases, in families of many nationalities and ethnic backgroun...

Efficacy and Safety of Micropulse Transscleral Laser Therapy in Silicone Oil-induced Gl...
https://doi.org/10.1097/IJG.0000000000002051
Journal of Glaucoma; Zbiba W, Sayadi S et. al.

May 19th, 2022 - To assess the efficiency and safety of MicroPulse® Transscleral Laser Therapy (TLT) in the management of silicone oil-induced glaucoma. A prospective case series of 33 eyes with uncontrolled silicone oil-induced glaucoma was enrolled at the depart...

Efficacy and Safety of the Preserflo Microshunt ® with Mytomicin C for the Treatment of...
https://doi.org/10.1097/IJG.0000000000002052
Journal of Glaucoma; Ibarz Barberá M, Galdón FM et. al.

May 19th, 2022 - The PSM® is a safe and effective glaucoma micro-filtering implant that significantly reduces the intraocular pressure, either alone or in combination with phacoemulsification, during the first year after surgery. To assess the safety and efficacy ...

Comparison of the Structure-function Relationship Between Advanced Primary Open-angle G...
https://doi.org/10.1097/IJG.0000000000002053
Journal of Glaucoma; Sung MS, Ji YS et. al.

May 19th, 2022 - To investigate and compare the characteristics of visual field (VF) defects in primary open-angle glaucoma (POAG) and normal tension glaucoma (NTG) with advanced glaucomatous damage and to determine whether the structure‒function relationships fou...

see more →

Guidelines  12 results

Primary Open-Angle Glaucoma Suspect Preferred Practice Pattern®.
https://doi.org/10.1016/j.ophtha.2020.10.023
Ophthalmology Gedde SJ, Lind JT et. al.

Dec 23rd, 2021 - Primary Open-Angle Glaucoma Suspect Preferred Practice Pattern®.|2021|Gedde SJ,Lind JT,Wright MM,Chen PP,Muir KW,|standards,standards,diagnosis,physiopathology,therapy,physiology,diagnosis,physiopathology,therapy,organization & administration,stan...

Primary Open-Angle Glaucoma Preferred Practice Pattern®.
https://doi.org/10.1016/j.ophtha.2020.10.022
Ophthalmology Gedde SJ, Vinod K et. al.

Dec 23rd, 2021 - Primary Open-Angle Glaucoma Preferred Practice Pattern®.|2021|Gedde SJ,Vinod K,Wright MM,Muir KW,Lind JT,|standards,standards,diagnosis,physiopathology,therapy,physiology,pathology,organization & administration,standards,pathology,

The Health Exam You Didn’t Know You Needed
https://www.aao.org/newsroom/news-releases/detail/health-exam-you-didnt-know-you-needed
American Academy of Ophthalmology

May 12th, 2021 - SAN FRANCISCO, Calif. – If you’re like most Americans surveyed in a recent Harris Poll, you probably thought you would notice a change in your vision if you had an eye disease. The fact is some of the leading causes of blindness—such as glaucoma o...

Staying away from the optic nerve: a formula for modifying glaucoma drainage device sur...
https://doi.org/10.1016/j.jaapos.2016.09.027
Journal of AAPOS : the Official Publication of the Americ... Margeta MA, Kuo AN et. al.

Jan 21st, 2017 - To provide guidelines for safe implantation of glaucoma drainage devices (GDDs) in small and pediatric eyes to avoid contact between the optic nerve (ON) and the posterior edge of the GDD plate. We developed a formula for calculating limbus-to-ON ...

Screening for Impaired Visual Acuity in Older Adults: Clinical Summary
https://allmedx.com/USPSTFPDF/viselderscrsumm.pdf

Feb 23rd, 2016 - Screening for Impaired Visual Acuity in Older Adults: Clinical Summary Population Adults 65 years or older who do not present with vision problems Recommendation No recommendation. Grade: I (insufficient evidence) Risk Assessment Older a...

see more →

Drugs  386 results see all →

Clinicaltrials.gov  612 results

Clinical and Molecular Studies in Families With Inherited Eye Disease
https://clinicaltrials.gov/ct2/show/NCT02771236

May 20th, 2022 - Objective: This project, Clinical and Molecular Studies in Families with Inherited Eye Disease will study inherited eye diseases, both Mendelian and complex age related inherited eye diseases, in families of many nationalities and ethnic backgroun...

Prospective Constitution of Database Gathering Data of Patients Suffering From Glaucoma Followed at University Hospital of Grenoble
https://clinicaltrials.gov/ct2/show/NCT02867527

May 18th, 2022 - Few publications provide information on the natural history of glaucoma, outside of clinical trials do not always reflect what is observed in common situation for various reasons (specific selection criteria and sometimes restrictive, stronger mot...

Self Tonometry and Transfer of Glaucoma Patients' Data for Improving the Supply Situation
https://clinicaltrials.gov/ct2/show/NCT04698876

May 17th, 2022 - The SALUS project is developing an outpatient, intersectoral form of care in which patients measure their intraocular pressure in their home environment with a so-called self-tonometer. The measured intraocular pressure values are incorporated int...

Visual Outcomes With a Trifocal IOL in Subjects With Open-angle Glaucoma
https://clinicaltrials.gov/ct2/show/NCT04619654

May 17th, 2022 - This study will examine the visual outcomes of subjects undergoing cataract surgery and minimally invasive glaucoma surgery with the implantation of a trifocal intraocular lens.

Topical Insulin for Glaucoma
https://clinicaltrials.gov/ct2/show/NCT05206877

May 13th, 2022 - The purpose of this Phase 1 trial is to determine the safety over 1-2 months of topic sterile human recombinant insulin on subjects with optic neuropathies (glaucoma, ischecmic optic neuropathy, and optic disc drusen).

see more →

News  738 results

The PreserFlo Ab-Externo MicroShunt: A Conversation With Dr Ike Ahmed
https://www.medscape.com/viewarticle/974081

May 19th, 2022 - Iqbal "Ike" K. Ahmed, MD, is a world-renowned ophthalmologist whose clinical work and research focus on glaucoma, complex cataracts, and intraocular lens complications. In 2020, The Ophthalmologist Power List named Dr Ahmed the second most influen...

Rheumatoid arthritis tied to increased risk of developing primary open-angle glaucoma
https://www.mdedge.com/rheumatology/article/254096/rheumatoid-arthritis/rheumatoid-arthritis-tied-increased-risk-developing

Apr 26th, 2022 - Key clinical point: Patients with seropositive rheumatoid arthritis (RA) were at a higher risk of developing primary open-angle glaucoma (POAG) compared with matched control participants, with risk being evident within 2 years after RA diagnosis a.

Oral, Topical Carbonic-Anhydrase Inhibitors for Glaucoma Similarly Safe
https://www.medscape.com/viewarticle/968083

Feb 9th, 2022 - NEW YORK (Reuters Health) - Whether glaucoma patients take carbonic-anhydrase inhibitors (CAIs) as pills or eye drops, the risk of severe adverse events is low, researchers in Canada report. There has been some reluctance among ophthalmologists to...

Specialized Spectacles Slow Myopia During Lockdown
https://www.medscape.com/viewarticle/966789

Jan 18th, 2022 - Specially designed spectacles can slow the progression of myopia, even during the lockdowns mandated by the COVID-19 pandemic, researchers say. Myopia progressed 46% more slowly in children prescribed defocus incorporated multiple segments (DIMS) ...

Ibrutinib/Rituximab Combo Represents Effective Chemo-Free Option for Elderly Patients with MCL
https://www.onclive.com/view/ibrutinib-rituximab-combo-represents-effective-chemo-free-option-for-elderly-patients-with-mcl

Jan 14th, 2022 - The combination of ibrutinib (Imbruvica) and rituximab (Rituxan) produced a high overall response rate (ORR) and durable survival in elderly patients with mantle cell lymphoma (MCL), according to data from a phase 2 ENRICH trial (NCT0180567) publi...

see more →

Patient Education  18 results see all →